Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

11.41
Delayed Data
As of Apr 24
 -0.32 / -2.73%
Today’s Change
10.85
Today|||52-Week Range
18.48
-19.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line-13.5M-22.4M-35.3M-40.3M
 
 
 
 
 
Depreciation32.0K56.0K97.0K121.0K
 
 
 
 
 
Total Other Cash Flow2.6M2.6M8.2M13.6M
 
 
 
 
 
Funds From Operations-10.9M-19.8M-27.0M-25.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-900.0K-2.2M-7.2M7.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.0M-17.6M-19.8M-33.6M
 
 
 
 
 
 
InvestingIncrease In Investments-49.8M4.5M-4.5M-46.0K
 
 
 
 
 
Decrease In Investments107.0K173.0K15.3M22.6M
 
 
 
 
 
Capital Expenditures-221.0K-565.0K-413.0K-290.0K
 
 
 
 
 
Net Cash Flow Investing-49.9M4.1M10.5M22.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale117.0M264.0K1.4M-6.1M
 
 
 
 
 
Common Preferred Redeemed-7.5M-65.0K0.007.5M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing109.5M199.0K1.4M1.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash49.6M-13.3M-7.9M-9.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account